DE69637155D1 - Addressine der schleimhaut und der blutgefässe und ihre verwendung - Google Patents

Addressine der schleimhaut und der blutgefässe und ihre verwendung

Info

Publication number
DE69637155D1
DE69637155D1 DE69637155T DE69637155T DE69637155D1 DE 69637155 D1 DE69637155 D1 DE 69637155D1 DE 69637155 T DE69637155 T DE 69637155T DE 69637155 T DE69637155 T DE 69637155T DE 69637155 D1 DE69637155 D1 DE 69637155D1
Authority
DE
Germany
Prior art keywords
madcam
primate
recombinant
proteins
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69637155T
Other languages
English (en)
Other versions
DE69637155T2 (de
Inventor
Michael J Briskin
Douglas J Ringler
Dominic Picarella
Walter Newman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27011628&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69637155(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/386,857 external-priority patent/US6551593B1/en
Priority claimed from US08/523,004 external-priority patent/US7750137B2/en
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of DE69637155D1 publication Critical patent/DE69637155D1/de
Application granted granted Critical
Publication of DE69637155T2 publication Critical patent/DE69637155T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • External Artificial Organs (AREA)
DE69637155T 1995-02-10 1996-02-12 Addressine der schleimhaut und der blutgefässe und ihre verwendung Expired - Lifetime DE69637155T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/386,857 US6551593B1 (en) 1995-02-10 1995-02-10 Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam
US386857 1995-02-10
US523004 1995-09-01
US08/523,004 US7750137B2 (en) 1995-09-01 1995-09-01 Mucosal vascular addressins
PCT/US1996/002153 WO1996024673A1 (en) 1995-02-10 1996-02-12 Mucosal vascular addressins and uses thereof

Publications (2)

Publication Number Publication Date
DE69637155D1 true DE69637155D1 (de) 2007-08-23
DE69637155T2 DE69637155T2 (de) 2008-02-07

Family

ID=27011628

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69637155T Expired - Lifetime DE69637155T2 (de) 1995-02-10 1996-02-12 Addressine der schleimhaut und der blutgefässe und ihre verwendung

Country Status (12)

Country Link
EP (1) EP0808367B1 (de)
JP (1) JP4205162B2 (de)
AT (1) ATE366809T1 (de)
AU (1) AU4986296A (de)
CA (1) CA2212702C (de)
DE (1) DE69637155T2 (de)
DK (1) DK0808367T3 (de)
ES (1) ES2290955T3 (de)
MX (1) MX9706049A (de)
NZ (1) NZ303523A (de)
PT (1) PT808367E (de)
WO (1) WO1996024673A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0948597A4 (de) * 1996-11-01 2002-07-10 Human Genome Sciences Inc Menschliches, Schleimhaut-spezifisches Addressin-Zelladhäsionsmolekül (MAdCAM-1) und dessen Spleissvarianten
AU7348798A (en) * 1997-05-09 1998-12-08 John P. Robarts Research Institute, The Method for dislodging infiltrated leukocytes from a tissue
ATE424417T1 (de) * 1998-05-13 2009-03-15 Genentech Inc Diagnose und behandlung von hepatischen krankheiten
AU2007201698B2 (en) * 1998-05-13 2011-10-13 Genentech, Inc. Diagnosis and treatment of hepatic disorders
US7090845B2 (en) 1998-05-13 2006-08-15 Genentech, Inc. Diagnosis and treatment of hepatic disorders
AUPR524101A0 (en) * 2001-05-25 2001-06-21 Council Of The Queensland Institute Of Medical Research, The Antigen targeting
WO2003047526A2 (en) * 2001-11-30 2003-06-12 Incyte Genomics, Inc. Cell adhesion and extracellular matrix proteins
WO2004081049A1 (en) * 2003-03-10 2004-09-23 Auckland Uniservices Limited Monoclonal antibodies that recognise mucosal addressin cell adhesion molecule-1 (madcam-1), soluble madcam-1 and uses thereof
MXPA05011751A (es) * 2003-05-01 2006-02-17 Scripps Research Inst Antagonistas de r-cadherina selectivos y metodos.
JP4315982B2 (ja) * 2004-01-09 2009-08-19 ファイザー インコーポレイティッド ＭＡｄＣＡＭに対する抗体
PT2322556E (pt) 2004-09-03 2016-02-15 Genentech Inc Antagonistas humanizados anti-beta7 e suas utilizações
ATE483732T1 (de) * 2005-07-08 2010-10-15 Pfizer Ltd Madcam-antikörper
WO2007007152A2 (en) * 2005-07-11 2007-01-18 Pfizer Limited Anti-madcam antibodies to treat metastatic cancers and chloroma
PL2279004T3 (pl) * 2008-05-16 2015-06-30 Hoffmann La Roche Zastosowanie biomarkerów do oceny leczenia zaburzeń zapalnych przewodu pokarmowego antagonistami integryny beta7
UY34054A (es) 2011-05-02 2012-11-30 Millennium Pharm Inc FORMULACIÓN PARA ANTICUERPO ANTI-a(alfa)4B(Beta)7
UA116189C2 (uk) 2011-05-02 2018-02-26 Мілленніум Фармасьютікалз, Інк. КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
US20170327584A1 (en) 2014-11-26 2017-11-16 Millennium Pharmaceuticals, Inc. Vedolizumab for the Treatment of Fistulizing Crohn's Disease
WO2016105572A1 (en) 2014-12-24 2016-06-30 Millennium Pharmaceuticals, Inc. PREDICTING OUTCOME OF TREATMENT WITH AN ANTI-α4β7 INTEGRIN ANTIBODY
MA41636A (fr) 2015-03-06 2018-01-09 Millennium Pharm Inc Méthode de traitement de la cholangite sclérosante primitive
WO2017160700A1 (en) 2016-03-14 2017-09-21 Millennium Pharmaceuticals, Inc. Methods of treating or preventing graft versus host disease
CA3017743A1 (en) 2016-03-14 2017-09-21 Millennium Pharmaceuticals, Inc. Method of preventing graft versus host disease
TW201735949A (zh) 2016-03-24 2017-10-16 千禧製藥公司 治療抗ctla4及抗pd-1組合治療中的胃腸道免疫相關不良事件之方法
JP7069032B2 (ja) 2016-03-24 2022-05-17 ミレニアム ファーマシューティカルズ， インコーポレイテッド がん免疫治療における胃腸の免疫関連有害事象の治療方法
EP3452070A1 (de) 2016-05-04 2019-03-13 Millennium Pharmaceuticals, Inc. Dreifachkombinationstherapie zur behandlung von entzündlicher darmerkrankung
EP3468597A1 (de) 2016-06-12 2019-04-17 Millennium Pharmaceuticals, Inc. Verfahren zur behandlung von entzündlicher darmerkrankung
WO2018104893A1 (en) 2016-12-06 2018-06-14 Glaxosmithkline Intellectual Property Development Limited Alpha4-beta7 antibodies with incrased fcrn binding and/or half-life
MX2019012749A (es) 2017-04-28 2020-02-03 Millennium Pharm Inc Metodos para tratar trastornos pediatricos.
CN111032694B (zh) 2017-07-14 2024-03-08 辉瑞大药厂 针对madcam的抗体
JP2022533702A (ja) * 2019-05-20 2022-07-25 パンディオン・オペレーションズ・インコーポレイテッド ＭＡｄＣＡＭ標的化免疫寛容

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5675794A (en) * 1992-12-15 1994-07-04 Board Of Trustees Of The Leland Stanford Junior University Mucosal vascular addressin, dna and expression

Also Published As

Publication number Publication date
CA2212702A1 (en) 1996-08-15
JP4205162B2 (ja) 2009-01-07
EP0808367A1 (de) 1997-11-26
WO1996024673A1 (en) 1996-08-15
JPH10513365A (ja) 1998-12-22
PT808367E (pt) 2007-10-22
ATE366809T1 (de) 2007-08-15
AU4986296A (en) 1996-08-27
NZ303523A (en) 2002-02-01
ES2290955T3 (es) 2008-02-16
DE69637155T2 (de) 2008-02-07
MX9706049A (es) 1998-02-28
EP0808367B1 (de) 2007-07-11
CA2212702C (en) 2010-04-20
DK0808367T3 (da) 2007-11-05

Similar Documents

Publication Publication Date Title
DE69637155D1 (de) Addressine der schleimhaut und der blutgefässe und ihre verwendung
Geiser et al. The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes
Senger et al. Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin
ES2063350T5 (es) Nuevas proteinas con efecto inhibidor del tnf y su obtencion.
KR101151805B1 (ko) 바이포달 펩타이드 바인더
JP2939557B2 (ja) フォン・ウィレブラント因子の５２／４８ｋＤａポリペプチドフラグメントから誘導可能なペプチド
US20060173162A1 (en) Bactericidak anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp)
Kokot et al. Tamm-Horsfall protein updated
Udby et al. Cysteine-rich secretory protein 3 is a ligand of α1B-glycoprotein in human plasma
CN102282169A (zh) 表达破骨细胞相关受体的细胞活性和分化的调节
KR970002917B1 (ko) 인터루킨-i 억제제
EP1683866B1 (de) Deletionsmutanten des IgE-abhängigen Histamin-Releasing-Faktor (HRF) mit der Fähigkeit zur Histaminfreisetzung, HRF-bindende Peptide sowie deren Verwendung
EA009414B1 (ru) Терапевтические применения вариантов хемокинов
KR100237936B1 (ko) 인터루킨-1 길항제
Campistol et al. Polymerization of normal and intact β2-microglobulin as the amyloidogenic protein in dialysis-amyloidosis
CA2208016A1 (en) Anti-inflammatory cd14 peptides
DK0486572T3 (da) Forbedringer i granulocyt-makrofag-kolonistimulerende faktorreceptor og derivater deraf
EP0698666B1 (de) Modifiziertes Epimorphin
JP3103531B2 (ja) ヒト尿由来細胞接着糖蛋白質及びその製造方法
Hensbergen et al. Processing of natural and recombinant CXCR3‐targeting chemokines and implications for biological activity
Deyl et al. Collagen αA and αB chains constitute two separate molecular species
CN101267829A (zh) 血小板反应蛋白-1的衍生肽以及治疗方法
Ashraf et al. Studies on immunological and degranulation properties of a galectin-1 purified from goat (Capra hircus) heart
CN114195876B (zh) 一种神经连接蛋白1的截短蛋白及其应用
KR19980024488A (ko) 혈액응고 제ⅹⅱ인자활성화법

Legal Events

Date Code Title Description
8363 Opposition against the patent